A 35-year-old patient presents to the clinic with frequent s…

A 35-year-old patient presents to the clinic with frequent shortness of breath, coughing, and wheezing that has not improved with standard asthma medications. The patient reports persistent nasal congestion and occasional loss of smell. Laboratory tests reveal elevated blood eosinophil counts, and sputum analysis confirms high eosinophil levels. Question:Based on the patient’s presentation, describe eosinophilic asthma and explain how it differs from other types of asthma. Include in your response: The underlying pathophysiology and immune response involved in eosinophilic asthma. How this condition is diagnosed, including key clinical findings and laboratory markers. The treatment methods commonly used for eosinophilic asthma, including how they differ from standard asthma therapies.

A newborn baby is admitted to the neonatal intensive care un…

A newborn baby is admitted to the neonatal intensive care unit with labored breathing, grunting, and cyanosis (bluish skin color). The infant was born prematurely at 30 weeks of gestation. A chest X-ray shows underinflated lungs, and the diagnosis of Infant Respiratory Distress Syndrome (IRDS) is made. Question:Using your understanding from “Pulmonary Surfactant: Alveoli’s Secreted Weapon,” explain the following: What causes IRDS and why it is common in premature infants. The role of pulmonary surfactant in preventing alveolar collapse, including the relationship between water’s cohesive forces and alveolar structure. How DPPC (dipalmitoylphosphatidylcholine) functions at the molecular level to reduce surface tension. Current treatment options for IRDS and how they help improve survival.